diabetic foot ulcer
Conditions
Interventions
experimental group:selective toe flexor tenotomy
Control group:Standard treatment protocol for diabetic foot, including: basic treatments such as glycemic control, anti-infection, and improvement of circulation
standard wound management for plantar ulcers
use of protective insoles or custom-made offloading shoes
medical education and lifestyle intervention.
Sponsors
Air Force Medical Center, PLA
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Aged 18 to 80 years, meeting the World Health Organization (WHO) diagnostic criteria for diabetes; patients with Wagner grade I–II diabetic foot ulcers; presence of obvious flexion deformity of the toes, with plantar ulcers corresponding to the site of metatarsophalangeal high pressure; ankle-brachial index (ABI) >= 0.7 indicating acceptable arterial blood supply to the foot; signed informed consent and voluntary participation in this study.
Exclusion criteria
Exclusion criteria: Patients with foot infection requiring surgical debridement or amputation; those with severe lower limb arterial occlusion (ABI < 0.7) or requiring revascularization; those with serious cardiovascular or cerebrovascular diseases, liver or kidney failure, or other conditions making them unsuitable for surgery; those with coagulation disorders or on anticoagulant therapy; pregnant or lactating women; those with mental disorders or poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ulcer recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| changes in plantar pressure distribution;rate of complete healing of foot ulcers;wound healing time;postoperative complication rate;toe range of motion and structural changes;pain score;quality of life assessment; | — |
Countries
China
Contacts
Public ContactDa Zhang
Air Force Medical Center, PLA
Outcome results
None listed